Abstract:
The invention relates to a printer comprising a scanning means provided in a housing, the scanning means arranged to move within the housing; mounting means for releasably mounting a printhead to the scanning means; an aperture provided within the housing, the aperture arranged to be placed on, or adjacent to, an image receiving medium such that the printhead, when mounted, is operable to print onto the image receiving medium through the aperture. In order to engrave an image into the image receiving medium it is proposed that the mounting means is arranged to accommodate a holding means which holds a machining device for machining a medium. Further, it is proposed that the printer is provided with an ink supply containing a security ink, especially for printing entry receipts onto the hand of a customer entering a discotheque or concert.
Abstract:
This invention relates to pharmaceutical compositions for use in the prevention, treatment and relief of indigestion, sour stomach, heartburn, gastroesophageal reflux, dyspepsia, constipation, over-indulgence and other gastrointestinal disorders in mammals, including humans, by administering compositions comprising: (i) an amount effective in the relief of gastrointestinal or esophagus disorders of an H2 antagonist selected from a compound of formula (I) and pharmaceutically acceptable salts, hydrates, stereoisomers or polymorphs thereof, and (ii) an amount effective in the relief of gastrointestinal or esophagus disorders and in the promotion of gastric emptying of a gastrointestinal motility agent such as cisapride, and optionally (iii) an amount effective in the relief of flatulence of simethicone or alpha-D-galactosidase.
Abstract:
This invention relates to pharmaceutical compositions for use in the treatment and relief of indigestion, sour stomach, heartburn and other gastrointestinal disorders in mammals, including humans, by administering compositions comprising: (i) an amount effective in the relief of gastrointestinal or esophagus disorders of an H2 antagonist selected from a compound of formula (I) and its pharmaceutically acceptable salts, hydrates, stereoisomers or polymorphs and (ii) an amount effective in relief of gastrointestinal or esophagus disorders of at least one of the alginates and (iii) an amount effective in relief of gastrointestinal distress of an antacid wherein the antacid provides a buffering effect and generates carbon dioxide to aerate the alginate.
Abstract:
This invention relates to pharmaceutical compositions for use in the treatment and relief of indigestion, sour stomach, heartburn and other gastrointestinal disorders in mammals, including humans, by administering compositions comprising: (i) an amount effective in the relief of gastrointestinal or esophagus disorders of an H2 antagonist selected from a compound of formula (I) and its pharmaceutically acceptable salts, hydrates, stereoisomers or polymorphs and (ii) an amount effective in relief of gastrointestinal or esophagus disorders of at least one of the alginates and optionally (iii) an anti-flatulent amount of simethicone.
Abstract:
This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and in the relief of indigestion, sour stomach, heartburn and other gastrointestinal disorders in mammals, including humans, by administering compositions comprising (i) an analgesically and anti-inflammatory effective amount of a salt of (S)-ibuprofen substantially free of (R)-ibuprofen wherein the salt is selected from (S)-ibuprofen-(S)-lysine and (S)-ibuprofen-(R)-lysine; and (ii) an amount effective in the relief of indigestion, sour stomach, heartburn, overindulgence and other gastrointestinal disorders of at least one of the H2 antagonists.
Abstract:
This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and the relief of nasal congestion and sinus pressure in a mammalian organism, said composition comprising: (i) an analgesically and anti-inflammatory effective amount of (S)-ibuprofen, or a salt thereof, substantially free of (R)-ibuprofen; and (ii) a sympathomimetically effective amount of at least one of the sympathomimetic amines selected from phenylephrine, phenylpropanolamine, pseudoephedrine, oxymetazoline, ephinephrine, naphazoline, xylometazoline, propylhexedrine, levo-desoxyephedrine or a therapeutically active stereoisomer thereof substantially free of its other stereoisomers or a pharmaceutically acceptable salt thereof.
Abstract:
This invention relates to a pharmaceutical composition for use in the relief of pain, cramps, bloating and tension experienced during menstruation or premenstruation in a female in need of such relief comprising administering to such female: (i) an analgesically and anti-inflammatory effective amount of (S)-ibuprofen, or a salt thereof, substantially free of (R)-ibuprofen; and (ii) a diuretically effective amount of a diuretic; and (iii) optionally a tension relieving effective amount of pyrilamine maleate.
Abstract:
Embodiments of methods and systems comprise identifying failing media and/or drives for a media library. Error data can be collected from media libraries. For each tape exhibiting an error rate of interest, a determination can be made whether the tape would still have been of interest had it not been loaded in certain drives. This information can be analyzed to identify failing drives or tapes.
Abstract:
Embodiments of methods and systems comprise collecting data associated with a library or library components and storing the collected data in repository. By collecting data associated with a library or library components and storing the collected data in a repository, the degradation of library components can be monitored and the reliability of library components determined, allowing unreliable components to be bypassed or replaced, enhancing the reliability of the library and preventing data loss.
Abstract:
This invention relates to pharmaceutical compositions for use in the treatment of pain and inflammation and the relief of allergy and cold symptoms in a mammalian organism, said composition comprising: (i) an analgesically and anti-inflammatory effective amount of (S)-ibuprofen, or a salt thereof, substantially free of (R)-ibuprofen; and (ii) an antihistaminically effective amount of at least one of the antihistamines or a therapeutically active stereoisomer thereof substantially free of its other stereoisomers.